Bubbli-Pred (Oral)
Generic name:prednisolone (oral route) [ pred-NIS-oh-lone ]
Drug class:Glucocorticoids
Medically reviewed by Drugs.com. Last updated on Jan 21, 2022.
The Bubbli-Pred brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Commonly used brand name(s)
In the U.S.
- Bubbli-Pred
- Cotolone
- Flo-Pred
- Millipred
- Millipred DP
- Orapred
- Orapred ODT
- Pediapred
- Prelone
- Veripred 20
In Canada
- Pms-prednisoLONE
Available Dosage Forms:
- Tablet
- Syrup
- Solution
- Tablet, Disintegrating
Therapeutic Class: Endocrine-Metabolic Agent
Pharmacologic Class: Adrenal Glucocorticoid
Uses for Bubbli-Pred
Prednisolone provides relief for inflamed areas of the body. It is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal problems, arthritis, asthma, blood or bone marrow problems, eye or vision problems, lupus, skin conditions, kidney problems, ulcerative colitis, and flare-ups of multiple sclerosis. Prednisolone is a corticosteroid (cortisone-like medicine or steroid). It works on the immune system to help relieve swelling, redness, itching, and allergic reactions.
This medicine is available only with your doctor's prescription.
Before using Bubbli-Pred
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of prednisolone in children. However, pediatric patients are more likely to have slower growth and bone problems if prednisolone is used for a long time. Recommended doses should not be exceeded, and the patient should be carefully monitored during therapy.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of prednisolone in the elderly. However, elderly patients are more likely to have age-related kidney and bone problems, which may require caution and an adjustment in the dose for elderly patients receiving prednisolone.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should...